Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
Gyre Therapeutics (GYRE) Stock Price & Analysis
797 Followers
GYRE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.81 - $30.40
Previous Close$15.16
Volume56.22K
Average Volume (3M)73.40K
Market Cap
$1.30B
Enterprise Value$1.29B
Total Cash (Recent Filing)$37.35M
Total Debt (Recent Filing)$275.00K
Price to Earnings (P/E)―
Beta0.72
Next Earnings
May 09, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jan 13, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-17.57
Shares Outstanding85,510,116
10 Day Avg. Volume38,424
30 Day Avg. Volume73,404
Standard Deviation1.35
R-Squared0.03
Alpha0.27
Financial Highlights & Ratios
Price to Book (P/B)16.58
Price to Sales (P/S)8.04
Price to Cash Flow (P/CF)79.00
P/FCF Ratio79.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue47.36
Enterprise Value/Gross Profit11.87
Enterprise Value/Ebitda146.58
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Gyre Therapeutics News
PremiumCompany Announcements
Gyre Therapeutics Seeks Compliance Amid Board Reshuffle
PremiumCompany Announcements
Gyre Therapeutics Advances with F230 IND Approval in China
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
GYRE FAQ
What was Gyre Therapeutics’s price range in the past 12 months?
Gyre Therapeutics lowest stock price was $4.81 and its highest was $30.40 in the past 12 months.
What is Gyre Therapeutics’s market cap?
Currently, no data Available
When is Gyre Therapeutics’s upcoming earnings report date?
Gyre Therapeutics’s upcoming earnings report date is May 09, 2024 which is 73 days ago.
How were Gyre Therapeutics’s earnings last quarter?
Currently, no data Available
Is Gyre Therapeutics overvalued?
According to Wall Street analysts Gyre Therapeutics’s price is currently Overvalued.
Does Gyre Therapeutics pay dividends?
Gyre Therapeutics pays a Annually dividend of $3.59 which represents an annual dividend yield of N/A. See more information on Gyre Therapeutics dividends here
What is Gyre Therapeutics’s EPS estimate?
Gyre Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gyre Therapeutics have?
Gyre Therapeutics has 85,510,120 shares outstanding.
What happened to Gyre Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Gyre Therapeutics?
Currently, no hedge funds are holding shares in GYRE
---
Gyre Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
GYRE Sentiment 50%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 7.1%
Last 30 Days ▲ 7.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
174.28%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
550.72%
Trailing 12-Months
Company Description
Gyre Therapeutics
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.
---
Technical Analysis
---